Temafloxacin
Temafloxacin
Temafloxacin (/tɛməˈflɒksəsɪn/) is a fluoroquinolone antibiotic that was removed from the U.S. market in 1992 due to serious adverse effects.
Etymology
The name "Temafloxacin" is derived from parts of the terms "tetrahydrofuryl methyl", "fluorine", and "quinolone", which describe the chemical structure of the drug. The "-floxacin" suffix is common to all drugs in the fluoroquinolone class.
Usage
Temafloxacin was used to treat bacterial infections, including those caused by Gram-negative bacteria. However, it was withdrawn from the market due to the risk of hemolytic-uremic syndrome, thrombotic thrombocytopenic purpura, and other serious blood disorders.
Related Terms
- Fluoroquinolone: A class of antibiotics that includes temafloxacin.
- Gram-negative bacteria: A type of bacteria that temafloxacin was used to treat.
- Hemolytic-uremic syndrome: A serious condition that can result from use of temafloxacin.
- Thrombotic thrombocytopenic purpura: Another serious condition that can result from use of temafloxacin.
External links
- Medical encyclopedia article on Temafloxacin
- Wikipedia's article - Temafloxacin
This WikiMD dictionary article is a stub. You can help make it a full article.
Languages: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski